Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYH1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | HMGCS1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | LYPLAL1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | AXL | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | GCSAM | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | GLS2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | BFSP2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | UBE2G1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | C11orf65 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | MAFA | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |